Authors: Conesa, A, Madrigal, P, Tarazona, S, Gomez-Cabrero D, Cervera, A, McPherson, A, Szczesniak, MW, Gaffney, DJ, Elo, LL, Zhang, XG, Mortazavi, A
Contributors: University of Helsinki, Research Programs Unit, Universitat Politècnica de València. Facultad de Administración y Dirección de Empresas - Facultat d'Administració i Direcció d'Empreses, European Commission, Ministerio de Economía y Competitividad, Juvenile Diabetes Research Foundation, EEUU
Source:
Genome Biology 17(1) 13 (2016)
Genome Biology
Subject Terms: RNA-seq, Next-generation sequencing, transcriptomics, differential gene expression, guidelines, standards, Expression quantitative trait loci, Systems biology, RNA-Seq, Computational biology, Genome browser, Functional genomics, Biology, Gene expression profiling, Alternative splicing, Genomics, DIFFERENTIAL EXPRESSION ANALYSIS, INTEGRATED ANALYSIS MMIA, DEEP SEQUENCING DATA, LARGE GENE LISTS, WEB-BASED TOOL, SINGLE-CELL, DNA-METHYLATION, PROSTATE-CANCER, SYSTEMS BIOLOGY, GENOME BROWSER, 318 Medical biotechnology, RNA-seq analysis, ESTADISTICA E INVESTIGACION OPERATIVA, Review, ta318
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::559e4d23ca2314210e08abe48972969c
https://www.repository.cam.ac.uk/handle/1810/253244
Authors: Alsinet C; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK. ca6@sanger.ac.uk.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK. ca6@sanger.ac.uk., Primo MN; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Lorenzi V; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Bello E; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Kelava I; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Jones CP; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Vilarrasa-Blasi R; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Sancho-Serra C; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Knights AJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Park JE; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Korea., Wyspianska BS; Open Targets, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.; Immunology Research Unit, Medicines Research Centre, GlaxoSmithKline, Stevenage, SG1 2NY, UK., Trynka G; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Tough DF; Immunology Research Unit, Medicines Research Centre, GlaxoSmithKline, Stevenage, SG1 2NY, UK., Bassett A; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Gaffney DJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK. dg13@sanger.ac.uk., Alvarez-Errico D; Josep Carreras Leukaemia Research Institute (IJC), Badalona, 08916, Barcelona, Catalonia, Spain. dalvarez@carrerasresearch.org., Vento-Tormo R; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK. rv4@sanger.ac.uk.
Source: Nature communications [Nat Commun] 2022 May 24; Vol. 13 (1), pp. 2885. Date of Electronic Publication: 2022 May 24.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Accede al texto completo Authors: Wei W; Department of Clinical Neuroscience, University of Cambridge, Cambridge, UK.; Medical Research Council Mitochondrial Biology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK., Gaffney DJ; Human Induced Pluripotent Stem Cell Initiative, Wellcome Genome Campus, Hinxton, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Chinnery PF; Department of Clinical Neuroscience, University of Cambridge, Cambridge, UK. pfc25@cam.ac.uk.; Medical Research Council Mitochondrial Biology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK. pfc25@cam.ac.uk.
Source: Nature communications [Nat Commun] 2021 Sep 02; Vol. 12 (1), pp. 5241. Date of Electronic Publication: 2021 Sep 02.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Authors: Berrens RV; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. rebecca.berrens@gmail.com.; Developmental Epigenetics, Department of Biochemistry, University of Oxford, Oxford, UK. rebecca.berrens@gmail.com., Yang A; European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK., Laumer CE; European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK., Lun ATL; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.; Genentech, South San Francisco, CA, USA., Bieberich F; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.; ETH Zürich, Basel, Switzerland., Law CT; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.; Department of Pathology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam, Hong Kong., Lan G; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.; School of Biomedical Sciences,Stem Cell and Regenerative Consortium, Centre for PanorOmic Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam, Hong Kong., Imaz M; Wellcome Sanger Institute, Cambridge, UK.; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Bowness JS; Developmental Epigenetics, Department of Biochemistry, University of Oxford, Oxford, UK., Brockdorff N; Developmental Epigenetics, Department of Biochemistry, University of Oxford, Oxford, UK., Gaffney DJ; Wellcome Sanger Institute, Cambridge, UK.; Genomics Plc, Oxford, UK., Marioni JC; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. marioni@ebi.ac.uk.; European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK. marioni@ebi.ac.uk.; Wellcome Sanger Institute, Cambridge, UK. marioni@ebi.ac.uk.
Source: Nature biotechnology [Nat Biotechnol] 2022 Apr; Vol. 40 (4), pp. 546-554. Date of Electronic Publication: 2021 Nov 15.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: MEDLINE
MeSH Terms: DNA Transposable Elements*/genetics , Induced Pluripotent Stem Cells*, Animals ; Humans ; Mice ; RNA
Authors: Marsh SE; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Walker AJ; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kamath T; Harvard Medical School, Boston, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Dissing-Olesen L; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Hammond TR; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA., de Soysa TY; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Young AMH; Wellcome-Medical Research Council Cambridge Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Murphy S; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA., Abdulraouf A; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Nadaf N; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Dufort C; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA., Walker AC; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA., Lucca LE; Department of Neurology and Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Kozareva V; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Vanderburg C; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Hong S; UK Dementia Research Institute, University College London, London, UK., Bulstrode H; Wellcome-Medical Research Council Cambridge Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Hutchinson PJ; Department of Clinical Neurosciences, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Gaffney DJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Hafler DA; Department of Neurology and Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Franklin RJM; Wellcome-Medical Research Council Cambridge Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Macosko EZ; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA., Stevens B; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA. beth.stevens@childrens.harvard.edu.; Harvard Medical School, Boston, MA, USA. beth.stevens@childrens.harvard.edu.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA. beth.stevens@childrens.harvard.edu.; Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA, USA. beth.stevens@childrens.harvard.edu.
Source: Nature neuroscience [Nat Neurosci] 2022 Mar; Vol. 25 (3), pp. 306-316. Date of Electronic Publication: 2022 Mar 08.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 9809671 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1726 (Electronic) Linking ISSN: 10976256 NLM ISO Abbreviation: Nat Neurosci Subsets: MEDLINE
MeSH Terms: Neuroglia* , Transcriptome*, Brain ; Humans ; Microglia/metabolism ; Sequence Analysis, RNA/methods ; Single-Cell Analysis/methods
Authors: De T; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.; Department of Genomics of Common Diseases, Imperial College London, London, UK.; Department of Metabolism, Imperial College London, London, UK., Goncalves A; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120 Heidelberg, Germany., Speed D; Bioinformatics Research Centre (BiRC), Aarhus University, Aarhus, Denmark.; Aarhus Institute of Advanced Studies (AIAS), Aarhus University, Aarhus, Denmark.; Quantitative Genetics and Genomics (QGG), Aarhus University, Aarhus, Denmark., Froguel P; Department of Genomics of Common Diseases, Imperial College London, London, UK.; Department of Metabolism, Imperial College London, London, UK.; Inserm UMR1283, CNRS UMR8199, European Genomic Institute for Diabetes (EGID), Université de Lille, Institut Pasteur de Lille, Lille University Hospital, Lille, France., Gaffney DJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Johnson MR; Department of Brain Sciences, Imperial College London, London, UK., Jarvelin MR; Centre for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.; Unit of Primary Health Care and Medical Research Center, Oulu University Hospital, Oulu, Finland.; Department of Epidemiology and Biostatistics, Medical Research Council-Public Health England Centre for Environment and Health, Imperial College London, London, UK.; Biocenter Oulu, University of Oulu, Oulu, Finland., Coin LJ; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.; Department of Genomics of Common Diseases, Imperial College London, London, UK.; Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Corporate Authors: NFBC consortium
Source: IScience [iScience] 2021 Jul 22; Vol. 24 (8), pp. 102893. Date of Electronic Publication: 2021 Jul 22 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Authors: Young AMH; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Kumasaka N; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Calvert F; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Hammond TR; FM Kirby Neurobiology Center, Boston Children's Hospital Harvard University, Boston, MA, USA.; Howard Hughes Medical Institute, Broad Institute of Harvard and MIT, Boston, MA, USA., Knights A; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Panousis N; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Park JS; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Schwartzentruber J; EMBL-EBI, Wellcome Genome Campus, Hinxton, UK., Liu J; Biogen, Cambridge, MA, USA., Kundu K; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Segel M; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Murphy NA; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., McMurran CE; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Bulstrode H; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Correia J; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Budohoski KP; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Joannides A; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Guilfoyle MR; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Trivedi R; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Kirollos R; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Morris R; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Garnett MR; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Timofeev I; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Jalloh I; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Holland K; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Mannion R; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Mair R; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Watts C; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK.; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, Birmingham, UK., Price SJ; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Kirkpatrick PJ; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Santarius T; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Mountjoy E; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Open Targets, Wellcome Genome Campus, Hinxton, UK., Ghoussaini M; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Open Targets, Wellcome Genome Campus, Hinxton, UK., Soranzo N; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Bayraktar OA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Stevens B; FM Kirby Neurobiology Center, Boston Children's Hospital Harvard University, Boston, MA, USA.; Howard Hughes Medical Institute, Broad Institute of Harvard and MIT, Boston, MA, USA., Hutchinson PJ; Division of Neurosurgery, Department of Clinical Neurosciences, Cambridge University Hospitals, Cambridge, UK., Franklin RJM; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. rjf1000@cam.ac.uk., Gaffney DJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. dg13@sanger.ac.uk.
Source: Nature genetics [Nat Genet] 2021 Jun; Vol. 53 (6), pp. 861-868. Date of Electronic Publication: 2021 Jun 03.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE
MeSH Terms: Gene Expression Regulation* , Transcription, Genetic*, Microglia/*metabolism, Alzheimer Disease/genetics ; Humans ; Models, Genetic ; Quantitative Trait Loci/genetics ; Sequence Analysis, RNA ; Single-Cell Analysis
Authors: Schwartzentruber J; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK. jeremys@ebi.ac.uk.; Open Targets, Wellcome Genome Campus, Cambridge, UK. jeremys@ebi.ac.uk.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. jeremys@ebi.ac.uk., Cooper S; Open Targets, Wellcome Genome Campus, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Liu JZ; Biogen, Cambridge, MA, USA., Barrio-Hernandez I; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK.; Open Targets, Wellcome Genome Campus, Cambridge, UK., Bello E; Open Targets, Wellcome Genome Campus, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Kumasaka N; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Young AMH; Wellcome-Medical Research Council Cambridge Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Franklin RJM; Wellcome-Medical Research Council Cambridge Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Johnson T; Target Sciences-R&D, GSK Medicines Research Centre, Stevenage, UK., Estrada K; BioMarin Pharmaceutical, San Rafael, CA, USA., Gaffney DJ; Open Targets, Wellcome Genome Campus, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.; Genomics Plc, Oxford, UK., Beltrao P; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK.; Open Targets, Wellcome Genome Campus, Cambridge, UK., Bassett A; Open Targets, Wellcome Genome Campus, Cambridge, UK. ab42@sanger.ac.uk.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. ab42@sanger.ac.uk.
Source: Nature genetics [Nat Genet] 2021 Apr; Vol. 53 (4), pp. 585-586.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: PubMed not MEDLINE; MEDLINE
Authors: Schwartzentruber J; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK. jeremys@ebi.ac.uk.; Open Targets, Wellcome Genome Campus, Cambridge, UK. jeremys@ebi.ac.uk.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. jeremys@ebi.ac.uk., Cooper S; Open Targets, Wellcome Genome Campus, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Liu JZ; Biogen, Cambridge, MA, USA., Barrio-Hernandez I; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK.; Open Targets, Wellcome Genome Campus, Cambridge, UK., Bello E; Open Targets, Wellcome Genome Campus, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Kumasaka N; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Young AMH; Wellcome-Medical Research Council Cambridge Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Franklin RJM; Wellcome-Medical Research Council Cambridge Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Johnson T; Target Sciences-R&D, GSK Medicines Research Centre, Stevenage, UK., Estrada K; BioMarin Pharmaceutical, San Rafael, CA, USA., Gaffney DJ; Open Targets, Wellcome Genome Campus, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.; Genomics Plc, Oxford, UK., Beltrao P; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK.; Open Targets, Wellcome Genome Campus, Cambridge, UK., Bassett A; Open Targets, Wellcome Genome Campus, Cambridge, UK. ab42@sanger.ac.uk.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. ab42@sanger.ac.uk.
Source: Nature genetics [Nat Genet] 2021 Mar; Vol. 53 (3), pp. 392-402. Date of Electronic Publication: 2021 Feb 15.
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE
MeSH Terms: Alzheimer Disease/*genetics, Adaptor Proteins, Signal Transducing/genetics ; Chromosome Mapping ; Cytoskeletal Proteins/genetics ; Gene Expression ; Genetic Predisposition to Disease ; Genome-Wide Association Study ; Humans ; Linkage Disequilibrium ; Microglia/physiology ; Oncogene Proteins/genetics ; Polymorphism, Single Nucleotide ; Protein Interaction Maps/genetics ; Quantitative Trait Loci ; Risk Factors ; Tetraspanins/genetics
Authors: Jerber J; Open Targets, Wellcome Genome Campus, Hinxton, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Seaton DD; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Cuomo ASE; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Kumasaka N; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Haldane J; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Steer J; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Patel M; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Pearce D; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Andersson M; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Bonder MJ; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Mountjoy E; Open Targets, Wellcome Genome Campus, Hinxton, Cambridge, UK., Ghoussaini M; Open Targets, Wellcome Genome Campus, Hinxton, Cambridge, UK., Lancaster MA; MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, UK., Marioni JC; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. marioni@ebi.ac.uk.; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. marioni@ebi.ac.uk.; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. marioni@ebi.ac.uk., Merkle FT; Metabolic Research Laboratories and Medical Research Council Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK. fm436@medschl.cam.ac.uk.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. fm436@medschl.cam.ac.uk., Gaffney DJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. dg13@sanger.ac.uk., Stegle O; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. o.stegle@dkfz-heidelberg.de.; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. o.stegle@dkfz-heidelberg.de.; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany. o.stegle@dkfz-heidelberg.de.; Division of Computational Genomics and Systems Genetics, German Cancer Research Center, Heidelberg, Germany. o.stegle@dkfz-heidelberg.de.
Corporate Authors: HipSci Consortium
Source: Nature genetics [Nat Genet] 2021 Mar; Vol. 53 (3), pp. 304-312. Date of Electronic Publication: 2021 Mar 04.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE
MeSH Terms: Quantitative Trait Loci* , Transcriptome*, Dopaminergic Neurons/*cytology , Dopaminergic Neurons/*physiology , Induced Pluripotent Stem Cells/*cytology, Cell Differentiation/genetics ; Genetic Predisposition to Disease ; Humans ; Induced Pluripotent Stem Cells/physiology ; Neurogenesis/genetics ; Oxidative Stress/drug effects ; Receptor, Fibroblast Growth Factor, Type 1/genetics ; Rotenone/toxicity ; Sequence Analysis, RNA ; Single-Cell Analysis
Authors: Heaton H; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. hh5@sanger.ac.uk., Talman AM; MIVEGEC, IRD, CNRS, University of Montpellier, Montpellier, France., Knights A; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Imaz M; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Gaffney DJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Durbin R; Department of Genetics, University of Cambridge, Cambridge, UK., Hemberg M; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. mh26@sanger.ac.uk., Lawniczak MKN; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. mara@sanger.ac.uk.
Source: Nature methods [Nat Methods] 2020 Jun; Vol. 17 (6), pp. 615-620. Date of Electronic Publication: 2020 May 04.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101215604 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1548-7105 (Electronic) Linking ISSN: 15487091 NLM ISO Abbreviation: Nat Methods Subsets: MEDLINE
MeSH Terms: RNA/*genetics , RNA-Seq/*methods , Single-Cell Analysis/*methods, Algorithms ; Base Sequence ; Cell Line ; Cluster Analysis ; Genotype ; Humans ; Polymorphism, Single Nucleotide ; Sensitivity and Specificity ; Software
Authors: Rawji KS; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Young AMH; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Ghosh T; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Michaels NJ; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Mirzaei R; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Kappen J; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Kolehmainen KL; University of British Columbia, ICORD, Vancouver, Canada., Alaeiilkhchi N; University of British Columbia, ICORD, Vancouver, Canada., Lozinski B; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Mishra MK; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Pu A; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Tang W; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Zein S; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Kaushik DK; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Keough MB; University of Alberta, Edmonton, Canada., Plemel JR; University of Alberta, Edmonton, Canada., Calvert F; Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Knights AJ; Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Gaffney DJ; Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Tetzlaff W; University of British Columbia, ICORD, Vancouver, Canada., Franklin RJM; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Yong VW; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada. vyong@ucalgary.ca.
Source: Acta neuropathologica [Acta Neuropathol] 2020 May; Vol. 139 (5), pp. 911.
Publication Type: Journal Article; Published Erratum
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Print Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: PubMed not MEDLINE; MEDLINE
Authors: Rawji KS; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Young AMH; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Ghosh T; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Michaels NJ; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Mirzaei R; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Kappen J; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Kolehmainen KL; University of British Columbia, ICORD, Vancouver, Canada., Alaeiilkhchi N; University of British Columbia, ICORD, Vancouver, Canada., Lozinski B; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Mishra MK; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Pu A; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Tang W; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Zein S; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Kaushik DK; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada., Keough MB; University of Alberta, Edmonton, Canada., Plemel JR; University of Alberta, Edmonton, Canada., Calvert F; Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Knights AJ; Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Gaffney DJ; Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Tetzlaff W; University of British Columbia, ICORD, Vancouver, Canada., Franklin RJM; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Yong VW; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 3330 Hospital Drive, Calgary, AB, T2N 4N1, Canada. vyong@ucalgary.ca.
Source: Acta neuropathologica [Acta Neuropathol] 2020 May; Vol. 139 (5), pp. 893-909. Date of Electronic Publication: 2020 Feb 06.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE
MeSH Terms: Aging/*physiology , Macrophages/*pathology , Microglia/*metabolism , Niacin/*metabolism , Rejuvenation/*physiology , Remyelination/*physiology, Animals ; Axons/pathology ; Demyelinating Diseases/pathology ; Humans ; Mice, Transgenic ; Microglia/pathology ; Multiple Sclerosis/pathology ; Phagocytosis/physiology
Authors: McCarthy DJ; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK.; St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.; Melbourne Integrative Genomics, School of Mathematics and Statistics/School of Biosciences, University of Melbourne, Parkville, Victoria, Australia., Rostom R; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Huang Y; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK., Kunz DJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Department of Physics, Cavendish Laboratory, Cambridge, UK.; The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK., Danecek P; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Bonder MJ; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK., Hagai T; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; School of Molecular Cell Biology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel., Lyu R; St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.; Melbourne Integrative Genomics, School of Mathematics and Statistics/School of Biosciences, University of Melbourne, Parkville, Victoria, Australia., Wang W; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gaffney DJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Simons BD; Department of Physics, Cavendish Laboratory, Cambridge, UK.; The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK.; The Wellcome Trust/Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, UK., Stegle O; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK. o.stegle@dkfz.de.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. o.stegle@dkfz.de.; European Molecular Biology Laboratory, Genome Biology Unit, Heidelberg, Germany. o.stegle@dkfz.de.; Division of Computational Genomics and Systems Genetics, German Cancer Research Center, Heidelberg, Germany. o.stegle@dkfz.de., Teichmann SA; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK. st9@sanger.ac.uk.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. st9@sanger.ac.uk.; Department of Physics, Cavendish Laboratory, Cambridge, UK. st9@sanger.ac.uk.
Corporate Authors: HipSci Consortium
Source: Nature methods [Nat Methods] 2020 Apr; Vol. 17 (4), pp. 414-421. Date of Electronic Publication: 2020 Mar 16.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101215604 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1548-7105 (Electronic) Linking ISSN: 15487091 NLM ISO Abbreviation: Nat Methods Subsets: MEDLINE
Authors: Conesa A; Institute for Food and Agricultural Sciences, Department of Microbiology and Cell Science, University of Florida, Gainesville, FL, 32603, USA. aconesa@ufl.edu.; Centro de Investigación Príncipe Felipe, Genomics of Gene Expression Laboratory, 46012, Valencia, Spain. aconesa@ufl.edu., Madrigal P; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK. pm12@sanger.ac.uk.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Anne McLaren Laboratory for Regenerative Medicine, Department of Surgery, University of Cambridge, Cambridge, CB2 0SZ, UK. pm12@sanger.ac.uk., Tarazona S; Centro de Investigación Príncipe Felipe, Genomics of Gene Expression Laboratory, 46012, Valencia, Spain.; Department of Applied Statistics, Operations Research and Quality, Universidad Politécnica de Valencia, 46020, Valencia, Spain., Gomez-Cabrero D; Unit of Computational Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, 171 77, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, 17177, Stockholm, Sweden.; Unit of Clinical Epidemiology, Department of Medicine, Karolinska University Hospital, L8, 17176, Stockholm, Sweden.; Science for Life Laboratory, 17121, Solna, Sweden., Cervera A; Systems Biology Laboratory, Institute of Biomedicine and Genome-Scale Biology Research Program, University of Helsinki, 00014, Helsinki, Finland., McPherson A; School of Computing Science, Simon Fraser University, Burnaby, V5A 1S6BC, Canada., Szcześniak MW; Department of Bioinformatics, Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University in Poznań, 61-614, Poznań, Poland., Gaffney DJ; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Elo LL; Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland., Zhang X; Key Lab of Bioinformatics/Bioinformatics Division, TNLIST and Department of Automation, Tsinghua University, Beijing, 100084, China.; School of Life Sciences, Tsinghua University, Beijing, 100084, China., Mortazavi A; Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA, 92697-2300, USA. ali.mortazavi@uci.edu.; Center for Complex Biological Systems, University of California, Irvine, Irvine, CA, 92697, USA. ali.mortazavi@uci.edu.
Source: Genome biology [Genome Biol] 2016 Aug 26; Vol. 17 (1), pp. 181. Date of Electronic Publication: 2016 Aug 26.
Publication Type: Published Erratum
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100960660 Publication Model: Electronic Cited Medium: Internet ISSN: 1474-760X (Electronic) Linking ISSN: 14747596 NLM ISO Abbreviation: Genome Biol
Authors: Abakir A; Department of Stem Cell Biology, University of Nottingham, Nottingham, UK., Giles TC; Advanced Data Analysis Centre, University of Nottingham, Sutton Bonington, UK.; Digital Research Service, University of Nottingham, Sutton Bonington, UK., Cristini A; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Foster JM; New England Biolabs, Inc., Ipswich, MA, USA., Dai N; New England Biolabs, Inc., Ipswich, MA, USA., Starczak M; Department of Clinical Biochemistry, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland., Rubio-Roldan A; GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain., Li M; Department of Microbiology, Oslo University Hospital, Oslo, Norway.; Department of Molecular Medicine, University of Oslo, Oslo, Norway., Eleftheriou M; Department of Stem Cell Biology, University of Nottingham, Nottingham, UK., Crutchley J; Department of Stem Cell Biology, University of Nottingham, Nottingham, UK., Flatt L; Department of Stem Cell Biology, University of Nottingham, Nottingham, UK., Young L; Department of Stem Cell Biology, University of Nottingham, Nottingham, UK., Gaffney DJ; Wellcome Sanger Institute, Cambridge, UK., Denning C; Department of Stem Cell Biology, University of Nottingham, Nottingham, UK., Dalhus B; Department of Microbiology, Oslo University Hospital, Oslo, Norway.; Department of Medical Biochemistry, University of Oslo, Oslo, Norway., Emes RD; Advanced Data Analysis Centre, University of Nottingham, Sutton Bonington, UK.; School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, UK., Gackowski D; Department of Clinical Biochemistry, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland., Corrêa IR Jr; New England Biolabs, Inc., Ipswich, MA, USA., Garcia-Perez JL; GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain.; MRC Human Genetics Unit, University of Edinburgh, Edinburgh, UK., Klungland A; Department of Microbiology, Oslo University Hospital, Oslo, Norway. arne.klungland@medisin.uio.no.; Department of Molecular Medicine, University of Oslo, Oslo, Norway. arne.klungland@medisin.uio.no., Gromak N; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK. natalia.gromak@path.ox.ac.uk., Ruzov A; Department of Stem Cell Biology, University of Nottingham, Nottingham, UK. alexey.ruzov@nottingham.ac.uk.
Source: Nature genetics [Nat Genet] 2020 Jan; Vol. 52 (1), pp. 48-55. Date of Electronic Publication: 2019 Dec 16.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE
MeSH Terms: Genomic Instability*, Adenosine/*analogs & derivatives , DNA/*chemistry , Pluripotent Stem Cells/*metabolism , RNA/*chemistry , RNA Stability/*drug effects , RNA-Binding Proteins/*physiology, Adenosine/pharmacology ; Animals ; DNA/drug effects ; DNA/genetics ; DNA Damage ; Humans ; Mice ; Mice, Knockout ; Mitosis ; Pluripotent Stem Cells/cytology ; RNA/drug effects ; RNA/genetics ; RNA, Messenger/chemistry ; RNA, Messenger/genetics ; RNA, Messenger/metabolism
Authors: Gaffney DJ; Wellcome Sanger Institute, Hinxton, UK. dg13@sanger.ac.uk.; Genomics plc, Cambridge, UK. dg13@sanger.ac.uk.
Source: Nature genetics [Nat Genet] 2019 Dec; Vol. 51 (12), pp. 1662-1663.
Publication Type: Journal Article; Comment
Journal Info: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE
MeSH Terms: Clustered Regularly Interspaced Short Palindromic Repeats* , Enhancer Elements, Genetic*, Promoter Regions, Genetic
Authors: Conesa A; Institute for Food and Agricultural Sciences, Department of Microbiology and Cell Science, University of Florida, Gainesville, FL, 32603, USA. aconesa@ufl.edu.; Centro de Investigación Príncipe Felipe, Genomics of Gene Expression Laboratory, 46012, Valencia, Spain. aconesa@ufl.edu., Madrigal P; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK. pm12@sanger.ac.uk.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Anne McLaren Laboratory for Regenerative Medicine, Department of Surgery, University of Cambridge, Cambridge, CB2 0SZ, UK. pm12@sanger.ac.uk., Tarazona S; Centro de Investigación Príncipe Felipe, Genomics of Gene Expression Laboratory, 46012, Valencia, Spain.; Department of Applied Statistics, Operations Research and Quality, Universidad Politécnica de Valencia, 46020, Valencia, Spain., Gomez-Cabrero D; Unit of Computational Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, 171 77, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, 17177, Stockholm, Sweden.; Unit of Clinical Epidemiology, Department of Medicine, Karolinska University Hospital, L8, 17176, Stockholm, Sweden.; Science for Life Laboratory, 17121, Solna, Sweden., Cervera A; Systems Biology Laboratory, Institute of Biomedicine and Genome-Scale Biology Research Program, University of Helsinki, 00014, Helsinki, Finland., McPherson A; School of Computing Science, Simon Fraser University, Burnaby, V5A 1S6, BC, Canada., Szcześniak MW; Department of Bioinformatics, Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University in Poznań, 61-614, Poznań, Poland., Gaffney DJ; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Elo LL; Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland., Zhang X; Key Lab of Bioinformatics/Bioinformatics Division, TNLIST and Department of Automation, Tsinghua University, Beijing, 100084, China.; School of Life Sciences, Tsinghua University, Beijing, 100084, China., Mortazavi A; Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA, 92697-2300, USA. ali.mortazavi@uci.edu.; Center for Complex Biological Systems, University of California, Irvine, Irvine, CA, 92697, USA. ali.mortazavi@uci.edu.
Source: Genome biology [Genome Biol] 2016 Jan 26; Vol. 17, pp. 13. Date of Electronic Publication: 2016 Jan 26.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100960660 Publication Model: Electronic Cited Medium: Internet ISSN: 1474-760X (Electronic) Linking ISSN: 14747596 NLM ISO Abbreviation: Genome Biol Subsets: MEDLINE
Authors: Schwartzentruber J; Wellcome Trust Sanger Institute, Hinxton, UK. jeremys@ebi.ac.uk.; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK. jeremys@ebi.ac.uk., Foskolou S; Pfizer Neuroscience and Pain Research Unit, Pfizer Ltd., Cambridge, UK., Kilpinen H; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK., Rodrigues J; Wellcome Trust Sanger Institute, Hinxton, UK., Alasoo K; Wellcome Trust Sanger Institute, Hinxton, UK., Knights AJ; Wellcome Trust Sanger Institute, Hinxton, UK., Patel M; Wellcome Trust Sanger Institute, Hinxton, UK., Goncalves A; Wellcome Trust Sanger Institute, Hinxton, UK., Ferreira R; Pfizer Neuroscience and Pain Research Unit, Pfizer Ltd., Cambridge, UK., Benn CL; Pfizer Neuroscience and Pain Research Unit, Pfizer Ltd., Cambridge, UK., Wilbrey A; Pfizer Neuroscience and Pain Research Unit, Pfizer Ltd., Cambridge, UK., Bictash M; Pfizer Neuroscience and Pain Research Unit, Pfizer Ltd., Cambridge, UK., Impey E; Pfizer Neuroscience and Pain Research Unit, Pfizer Ltd., Cambridge, UK., Cao L; Pfizer Neuroscience and Pain Research Unit, Pfizer Ltd., Cambridge, UK., Lainez S; Pfizer Neuroscience and Pain Research Unit, Pfizer Ltd., Cambridge, UK., Loucif AJ; Pfizer Neuroscience and Pain Research Unit, Pfizer Ltd., Cambridge, UK., Whiting PJ; Pfizer Neuroscience and Pain Research Unit, Pfizer Ltd., Cambridge, UK.; AR-UK Drug Discovery Institute, Institute of Neurology, University College London, London, UK., Gutteridge A; Pfizer Neuroscience and Pain Research Unit, Pfizer Ltd., Cambridge, UK. alex.x.gutteridge@gsk.com., Gaffney DJ; Wellcome Trust Sanger Institute, Hinxton, UK. dg13@sanger.ac.uk.
Corporate Authors: HIPSCI Consortium
Source: Nature genetics [Nat Genet] 2019 Jul; Vol. 51 (7), pp. 1190.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: PubMed not MEDLINE
Authors: Alasoo K; Institute of Computer Science, University of Tartu, Tartu, Estonia.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom., Rodrigues J; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom., Danesh J; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.; BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; British Heart Foundation Centre of Excellence, Division of Cardiovascular Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom.; National Institute for Health Research Blood and Transplant Unit (NIHR BTRU) in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Freitag DF; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.; British Heart Foundation Centre of Excellence, Division of Cardiovascular Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom., Paul DS; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.; British Heart Foundation Centre of Excellence, Division of Cardiovascular Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom., Gaffney DJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.
Source: ELife [Elife] 2019 Jan 08; Vol. 8. Date of Electronic Publication: 2019 Jan 08.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE